Used MMIT real-world data to uncover hidden market-access opportunities
Used MMIT real-world data to uncover hidden market-access opportunities
The customer is anonymised in Norstella’s own case study — not withheld by us.
Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Norstella on its own site — read the original case study on mmitnetwork.com ↗
Note: Original URL 301-redirected to www.norstella.com/linq/, a generic NorstellaLinQ product marketing page (headline "Follow the Patient, Not the Data Fragments") with no case study matching the old description (hidden opportunities / possibly KORU Medical). No verifiable case-specific content could be extracted.
Related use cases
- 01Empowering Early Disease Diagnosis with Real-World Data
- 02Refining Rare Disease Targeting with Real-World Data
- 03Gain Real-Time Insights on High-Risk Patient Populations with Real-World Data
- 04Powering Unbiased Outcomes Research with Longitudinal Data
- 05NorstellaLinQ: Better Together: Getting the Full Patient Picture
- 06Trial Rescue & Reconnaissance